Home Dialysis Plus
Patients and their healthcare providers with home hemodialysis solutions
About Home Dialysis Plus
Home Dialysis Plus, Ltd. (HD+) is a medical device company concentrated on advancing home hemodialysis treatments for individuals with end-stage renal disease. The company is developing a portable dialysis system engineered to allow for more frequent treatments, which closely mimics the natural function of kidneys and has been shown to improve a patient's quality of life. This contrasts with the standard in-clinic regimen of three four-hour sessions per week, a schedule that can be physically and emotionally demanding for patients. The HD+ system is designed to provide a gentler, nocturnal treatment, enabling patients to undergo dialysis while they sleep.
The core of the HD+ system relies on licensed and patented technologies. In 2008, the company signed an exclusive global licensing agreement with Oregon State University for its Micro-scale Energy and Chemical Systems (MECS) technology for use in blood filtration and water treatment for dialysis. MECS technology miniaturizes chemical processes using micro-channels, which enhances efficiency and significantly reduces the size of the device, making it portable. This technology is expected to decrease the required amount of dialysate and the volume of blood outside the body at any given time compared to conventional machines. The system also incorporates licensed inkjet technology from HP.
The business operates in the growing home dialysis market, which serves patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Its business model focuses on providing these patients, along with their doctors and care providers, a cost-effective and patient-friendly alternative to traditional in-clinic dialysis. By enabling treatment at home, the system offers greater flexibility and convenience. The company's revenue model will likely be based on the sale of these portable hemodialysis machines and related consumables to healthcare providers and patients. In 2010, Home Dialysis Plus secured a significant financial commitment of up to $50 million from the private equity firm Warburg Pincus to fund the commercialization of its new system. This investment followed earlier funding from the Oregon Nanoscience and Microtechnologies Institute (ONAMI) and the Oregon State Venture Fund. To accelerate development, HD+ formed a strategic partnership with StarFish Medical for product development and system integration services.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2018 | $132M | $528M | Warburg Pincus · T. Rowe Price · Mubadala Capital | ↗ |
| SERIES COther financing | May 2017 | $77M | $306M | Warburg Pincus · Fidelity Investments · The Vertical Group · Perceptive Advisors | — |
Growth signals
Latest recorded traffic for Home Dialysis Plus is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Home Dialysis Plus in the Stafford ecosystem
The Home Dialysis Plus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
T. Rowe Price
Warburg Pincus
Fidelity Investments
The Vertical Group
Perceptive Advisors
Mubadala Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Home Dialysis Plus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Home Dialysis Plus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










